NYSE Euronext (NYX) today announced trading volumes for its
global derivatives and cash equities exchanges for June 20131.
Global derivatives average daily volume (“ADV”) of 8.7 million
contracts, excluding Bclear in June 2013 increased 32.6% compared
to June 2012 and increased 15.7% from May 2013. U.S. equity options
volumes remained strong in June 2013 increasing 24.0% compared to
June 2012 and increasing 3.3% sequentially. ADV in U.S. cash
equities declined 2.2% year-over-year, but increased 18.6%
month-over-month. European cash equities ADV in June 2013 decreased
9.1% compared to June 2012, but increased 8.0% from May 2013
levels.
Highlights
- NYSE Euronext global derivatives ADV in
June 2013 of 8.7 million contracts increased 32.6% from June 2012,
and increased 15.7% from May 2013 levels.
- NYSE Euronext European derivatives
products ADV in June 2013 of 4.2 million contracts, excluding
Bclear, increased 44.2% compared to June 2012, and increased 31.6%
from May 2013 levels. Including Bclear, NYSE Liffe’s trade
administration and clearing service for OTC products, European
derivatives ADV increased 3.7% compared to June 2012, and increased
21.4% from May 2013.
- NYSE Euronext U.S. equity options (NYSE
Arca and NYSE Amex Options) ADV of 4.5 million contracts in June
2013 increased 24.0% compared to June 2012 levels, and increased
3.3% from May 2013 levels. NYSE Euronext’s U.S. options exchanges
accounted for 27.5% of total U.S. consolidated equity options
trading in June 2013, up from 25.6% in June 2012, and up from 27.2%
in May 2013.
- NYSE Liffe U.S. ADV of approximately
96,400 contracts increased from 90,900 contracts in June 2012, and
increased from 50,000 contracts in May 2013.
- NYSE Euronext European cash products
ADV of 1.5 million transactions in June 2013 decreased 9.1%
compared to June 2012, but increased 8.0% compared to May
2013.
- NYSE Euronext U.S. cash products (NYSE,
NYSE Arca and NYSE MKT) handled ADV of 1.8 billion shares in June
2013 decreased 2.2% compared to June 2012, but increased 18.6%
compared to May 2013. NYSE Euronext’s Tape A matched market share
in June 2013 was 32.4%, down slightly from 32.5% in June 2012, but
up from 30.0% in May 2013.
- The preliminary average net revenue per
transaction type (as defined below) for each of the primary trading
venues in the second quarter of 2013 is included below:
Preliminary
Trading Venue 2Q12
1Q13 2Q13 European Derivatives (ex.
Bclear)1 $0.674 $0.622 $0.61
U.S. Derivatives2 $0.150 $0.150
$0.15 European Cash3 $0.519
$0.620 $0.55 U.S. Cash4
$0.043 $0.043
$0.04
1 Average net revenue per contract,
excluding Bclear.
2 Average net revenue per contract.
Excludes NYSE Liffe U.S. trading volume.
3 Average net revenue per transaction.
4 Average net revenue per 100 shares
handled.
Other Metrics
- The average EUR/USD exchange rate for
the second quarter of 2013 of $1.31 represented a decrease of 1.1%
from the first quarter of 2013 and an increase of 1.7% compared to
the second quarter of 2012. The average GBP/USD exchange rate for
the second quarter of 2013 of $1.54 represented a decrease of 1.1%
from the first quarter of 2013 and a decrease of 3.0% compared to
the second quarter of 2012.
________________________________
1 All NYSE Euronext derivatives transactions count buy and sell
orders together as a single transaction. NYSE Euronext European
equities transactions count each buy and sell order as separate
transactions, NYSE Euronext U.S. equities transactions count buy
and sell orders together as a single transaction.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial
markets and provider of innovative trading technologies. The
company's exchanges in Europe and the United States trade equities,
futures, options, fixed-income and exchange-traded products. With
approximately 8,000 listed issues (excluding European Structured
Products), NYSE Euronext's equities markets - the New York Stock
Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca -
represent one-third of the world’s equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates
NYSE Liffe, one of the leading European derivatives businesses and
the world's second-largest derivatives business by value of
trading. The company offers comprehensive commercial technology,
connectivity and market data products and services through NYSE
Technologies. NYSE Euronext is in the S&P 500 index. For more
information, please visit: http://www.nyx.com.
Please follow us at:
Exchanges BlogFacebookLinkedInTwitter
CAUTIONARY STATEMENT REGARDING FORWARD LOOKING
STATEMENTS
This written communication contains “forward-looking statements”
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. In some cases, you can
identify forward-looking statements by words such as “may,” “hope,”
“will,” “should,” “expect,” “plan,” “anticipate,” “intend,”
“believe,” “estimate,” “predict,” “potential,” “continue,” “could,”
“future” or the negative of those terms or other words of similar
meaning. You should carefully read forward-looking statements,
including statements that contain these words, because they discuss
our future expectations or state other “forward-looking”
information. Forward-looking statements are subject to numerous
assumptions, risks and uncertainties which change over time. ICE
Group, ICE and NYSE Euronext caution readers that any
forward-looking statement is not a guarantee of future performance
and that actual results could differ materially from those
contained in the forward-looking statement.
Forward-looking statements include, but are not limited to,
statements about the benefits of the proposed merger involving ICE
Group, ICE and NYSE Euronext, including future financial results,
ICE’s and NYSE Euronext’s plans, objectives, expectations and
intentions, the expected timing of completion of the transaction
and other statements that are not historical facts. Important
factors that could cause actual results to differ materially from
those indicated by such forward-looking statements are set forth in
ICE’s and NYSE Euronext’s filings with the U.S. Securities and
Exchange Commission (the “SEC”). These risks and uncertainties
include, without limitation, the following: the inability to close
the merger in a timely manner; the failure to satisfy other
conditions to completion of the merger, including receipt of
required regulatory and other approvals; the failure of the
proposed transaction to close for any other reason; the possibility
that any of the anticipated benefits of the proposed transaction
will not be realized; the risk that integration of NYSE Euronext’s
operations with those of ICE will be materially delayed or will be
more costly or difficult than expected; the challenges of
integrating and retaining key employees; the effect of the
announcement of the transaction on ICE’s, NYSE Euronext’s or the
combined company’s respective business relationships, operating
results and business generally; the possibility that the
anticipated synergies and cost savings of the merger will not be
realized, or will not be realized within the expected time period;
the possibility that the merger may be more expensive to complete
than anticipated, including as a result of unexpected factors or
events; diversion of management’s attention from ongoing business
operations and opportunities; general competitive, economic,
political and market conditions and fluctuations; actions taken or
conditions imposed by the United States and foreign governments or
regulatory authorities; and adverse outcomes of pending or
threatened litigation or government investigations. In addition,
you should carefully consider the risks and uncertainties and other
factors that may affect future results of the combined company, as
are described in the section entitled “Risk Factors” in the joint
proxy statement/prospectus filed by ICE Group with the SEC, and as
described in ICE’s and NYSE Euronext’s respective filings with the
SEC that are available on the SEC’s web site located at
www.sec.gov, including the sections entitled “Risk Factors” in
ICE’s Form 10-K for the fiscal year ended December 31, 2012, as
filed with the SEC on February 6, 2013, and “Risk Factors” in NYSE
Euronext’s Form 10-K for the fiscal year ended December 31, 2012,
as filed with the SEC on February 26, 2013. You should not place
undue reliance on forward-looking statements, which speak only as
of the date of this written communication. Except for any
obligations to disclose material information under the Federal
securities laws, ICE Group, ICE and NYSE Euronext undertake no
obligation to publicly update any forward-looking statements to
reflect events or circumstances after the date of this written
communication.
IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND WHERE
TO FIND IT
This communication does not constitute an offer to sell or the
solicitation of an offer to buy any securities or a solicitation of
any vote or approval. In connection with the proposed transaction,
ICE Group has filed with the SEC a registration statement on Form
S−4, which the SEC has declared effective and which contains a
joint proxy statement/prospectus with respect to the proposed
acquisition of NYSE Euronext by ICE Group. The final joint proxy
statement/prospectus has been delivered to the stockholders of ICE
and NYSE Euronext. INVESTORS AND SECURITY HOLDERS OF BOTH ICE AND
NYSE EURONEXT ARE URGED TO READ THE JOINT PROXY
STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION CAREFULLY
AND IN ITS ENTIRETY, INCLUDING ANY DOCUMENTS PREVIOUSLY FILED WITH
THE SEC AND INCORPORATED BY REFERENCE INTO THE JOINT PROXY
STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO
THOSE DOCUMENTS, BECAUSE IT CONTAINS IMPORTANT INFORMATION
REGARDING ICE, NYSE EURONEXT AND THE PROPOSED TRANSACTION.
Investors and security holders may obtain a free copy of the joint
proxy statement/prospectus, as well as other filings containing
information about ICE and NYSE Euronext, without charge, at the
SEC’s website at http://www.sec.gov. Investors may also obtain
these documents, without charge, from ICE’s website at
http://www.theice.com and from NYSE Euronext’s website at
http://www.nyx.com.
NYSE
Euronext
Monthly Volume
Summary
Average Daily Volume Total
Volume Average Daily Volume
Total Volume
% Chg vs.
% Chg vs.
(Unaudited; contracts in thousands)
Jun-13
Jun-12 % Chg
Jun-13 Jun-12 %
Chg YTD 2013
YTD 2012
YTD 2013
YTD 2012
Number of Trading Days - European Cash 20 21 20 21 125 125
Number of Trading Days - European Derivatives 20 21 20 21 126 126
Number of Trading Days - U.S. Markets 20 21 20 21 124 124
European Derivatives Products 4,769 4,597
3.7% 95,386 96,544 -1.2% 4,278
7.4% 539,024 5.7% of which Bclear 612 1,714
-64.3% 12,244 35,998 -66.0% 815 -32.1% 102,666 -33.1%
Total Fixed Income Products 3,257 1,924
69.3% 65,138 40,401 61.2% 2,604
39.8% 328,087 37.6% Short Term Interest
Rate Products 3,059 1,783 71.5% 61,179 37,451 63.4% 2,416 41.3%
304,398 39.0%
Medium and Long Term Interest Rate
Products 1
198 140 40.9% 3,959 2,950 34.2% 188 23.6% 23,689 21.7%
Total Equity Products 2
1,416 2,592 -45.4% 28,313 54,432
-48.0% 1,584 -22.4% 199,534
-23.6% Individual Equity Products 748 2,005 -62.7%
14,960 42,111 -64.5% 1,047 -31.7% 131,980 -32.8% Futures 390 1,517
-74.3% 7,809 31,854 -75.5% 633 -39.6% 79,755 -40.5% Options 358 488
-26.8% 7,151 10,257 -30.3% 414 -14.7% 52,226 -16.0% Equity Index
Products 668 587 13.8% 13,353 12,321 8.4% 536 5.9% 67,554 4.2%
of which Bclear 611 1,714 -64.3% 12,227 35,998 -66.0% 814
-32.2% 102,525 -33.2% Individual Equity Products 468 1,621 -71.1%
9,358 34,044 -72.5% 703 -37.5% 88,633 -38.5% Futures 385 1,512
-74.5% 7,709 31,759 -75.7% 613 -40.0% 77,299 -41.0% Options 82 109
-24.2% 1,649 2,284 -27.8% 90 -11.8% 11,334 -13.2% Equity Index
Products 143 93 54.1% 2,869 1,955 46.8% 110 48.0% 13,892 45.7%
Commodity Products 97 82 18.8%
1,936 1,712 13.1% 90 13.3%
11,403 11.5% U.S. Derivatives Products
Equity Options 3
NYSE Euronext Options Contracts 4,493 3,624 24.0% 89,863
76,103 18.1% 4,306 7.1% 533,914 6.2% Total Consolidated Options
Contracts 16,345 14,183 15.2% 326,896 297,841 9.8% 15,445 0.3%
1,915,146 -0.5% NYSE Group Share of Total 27.5% 25.6% 27.5%
25.6% 27.9% 1.8% 27.9% 1.8%
NYSE Liffe U.S.
Futures and Futures Options Volume* 96.3 90.9 6.0% 1,926 1,908 0.9%
61.0 -28.0% 7,752.8 -29.1%
European Cash Products (trades
in thousands) 1,516 1,668 -9.1%
30,321 35,034 -13.5% 1,424
-13.4% 178,020 -14.8% Equities 1,461
1,617 -9.7% 29,211 33,966 -14.0% 1,372 -13.8% 171,551 -15.1%
Exchange-Traded Funds 17 14 28.1% 350 287 22.0% 14 -1.2% 1,780
-2.8% Structured Products 33 32 4.1% 662 668 -0.8% 32 -4.7% 4,030
-6.2% Bonds 5 5 -9.4% 98 114 -13.8% 5 6.6% 658 4.9%
U.S. Cash Products (shares in
millions) 5
1,811 1,852 -2.2% 36,229 38,902
-6.9% 1,587 -12.0% 196,764
-12.7% NYSE Listed (Tape A) Issues 4
Handled Volume 5 1,278 1,335 -4.3% 25,559 28,040 -8.8% 1,138
-11.8% 141,077 -12.5% Matched Volume 6 1,236 1,277 -3.2% 24,710
26,813 -7.8% 1,096 -10.3% 135,865 -11.0% Total NYSE Listed
Consolidated Volume 3,809 3,930 -3.1% 76,171 82,527 -7.7% 3,597
-8.0% 446,022 -8.7%
Share of Total Consolidated
Volume Handled Volume 5 33.6% 34.0% -0.4% 33.6% 34.0% -0.4%
31.6% -1.4% 31.6% -1.4% Matched Volume 6 32.4% 32.5% -0.1% 32.4%
32.5% -0.1% 30.5% -0.8% 30.5% -0.8%
NYSE Arca, MKT and
Regional (Tape B) Listed Issues Handled Volume 5 353 291
21.2% 7,054 6,110 15.5% 256 -5.9% 31,764 -6.6% Matched Volume 6 324
264 22.9% 6,484 5,542 17.0% 236 -3.3% 29,258 -4.1% Total NYSE Arca
& MKT Listed Consolidated Volume 1,497 1,215 23.2% 29,933
25,507 17.4% 1,125 -2.7% 139,508 -3.4%
Share of Total
Consolidated Volume Handled Volume 5 23.6% 24.0% -0.4% 23.6%
24.0% -0.4% 22.8% -0.8% 22.8% -0.8% Matched Volume 6 21.7% 21.7%
0.0% 21.7% 21.7% 0.0% 21.0% -0.1% 21.0% -0.1%
Nasdaq
Listed (Tape C) Issues Handled Volume 5 181 226 -20.1%
3,616 4,752 -23.9% 193 -20.2% 23,923 -20.8% Matched Volume 6 162
196 -17.3% 3,237 4,109 -21.2% 172 -16.3% 21,368 -16.9% Total Nasdaq
Listed Consolidated Volume 1,879 1,790 5.0% 37,590 37,595 0.0%
1,801 0.1% 223,295 -0.7%
Share of Total Consolidated
Volume Handled Volume 5 9.6% 12.6% -3.0% 9.6% 12.6% -3.0% 10.7%
-2.7% 10.7% -2.7% Matched Volume 6 8.6% 10.9% -2.3% 8.6% 10.9%
-2.3% 9.6% -1.8% 9.6% -1.8%
Exchange-Traded Products
5,7 Handled Volume 5 321 271 18.6% 6,422 5,684 13.0%
241 -6.3% 29,827 -7.1% Matched Volume 6 294 245 20.0% 5,876 5,140
14.3% 221 -3.6% 27,455 -4.4% Total ETF Consolidated Volume 1,444
1,181 22.3% 28,873 24,792 16.5% 1,085 -3.6% 134,573 -4.3%
Share of Total Consolidated Volume Handled Volume 5 22.2%
22.9% -0.7% 22.2% 22.9% -0.7% 22.2% -0.7% 22.2% -0.7% Matched
Volume 6 20.4% 20.7% -0.3% 20.4% 20.7% -0.3% 20.4% 0.0% 20.4% 0.0%
1 Data includes currency products.
2
Includes all trading activities for Bclear, NYSE Liffe's clearing
service for wholesale derivatives. 3 Includes trading in U.S.
equity options contracts, not equity-index options. 4 Includes all
volume executed in NYSE Group crossing sessions. 5 Represents the
total number of shares of equity securities and ETFs internally
matched on the NYSE Group's exchanges or routed to and executed at
an external market center. NYSE Arca routing includes odd-lots. 6
Represents the total number of shares of equity securities and ETFs
executed on the NYSE Group's exchanges. 7 Data included in
previously identified categories. * ADVs calculated with the
appropriate number of NYSE Liffe U.S. trading days. Source: NYSE
Euronext, Options Clearing Corporation and Consolidated Tape as
reported for equity securities. All trading activity is
single-counted, except European cash trading which is double
counted to include both buys and sells.
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Lug 2023 a Lug 2024